CIK 0001427925
- Non-accelerated filer
- Smaller reporting company
TALPHERA, INC.
Sign in to watch- Ticker
- TLPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 412193603
- Phone
- +1 650-216-3500
- Business address
- 1850 GATEWAY DRIVE, SUITE 175, SAN MATEO, CA, 94404
- Former names
- ACELRX PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2012-02-07 | Hamel Lawrence G Chief Development Officer | Grant or award · Stock Option (Right to Buy) | +51,319 | 51,319 | ||
| 2012-02-07 | Hamel Lawrence G Chief Development Officer | Grant or award · Stock Option (Right to Buy) | +51,319 | 51,319 | ||
| 2011-12-01 | EDWARDS MARK G Director | Purchase | +10,000 | $2.79 | $28K | 50,000 |
| 2011-11-14 | EDWARDS MARK G Director | Purchase | +40,000 | $2.90 | $116K | 40,000 |
| 2011-09-26 | EDWARDS MARK G Director | Returned to the company · Stock Option (Right to Buy) | −11,666 | 3,334 | ||
| 2011-09-26 | EDWARDS MARK G Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2011-09-07 | WELCH JAMES H Chief Financial Officer | Purchase | +2,000 | $3.39 | $7K | 14,000 |
| 2011-09-07 | WELCH JAMES H Chief Financial Officer | Purchase | +1,000 | $3.39 | $3K | 15,000 |
| 2011-09-06 | WELCH JAMES H Chief Financial Officer | Purchase | +7,000 | $3.32 | $23K | 12,000 |
| 2011-09-02 | Hamel Lawrence G Chief Development Officer | Shares withheld for taxes | −1,539 | $3.10 | $5K | 15,360 |
| 2011-09-02 | Dasu Badri N Chief Engineering Officer | Shares withheld for taxes | −1,354 | $3.10 | $4K | 13,517 |
| 2011-08-29 | SCHRECK THOMAS A Director | Purchase | +500 | $3.27 | $2K | 300,951 |
| 2011-08-29 | SCHRECK THOMAS A Director | Purchase | +500 | $3.28 | $2K | 17,982 |
| 2011-08-24 | SCHRECK THOMAS A Director | Purchase | +1,000 | $3.01 | $3K | 300,451 |
| 2011-08-24 | SCHRECK THOMAS A Director | Purchase | +1,000 | $3.01 | $3K | 17,482 |
| 2011-06-09 | Palmer Pamela P Chief Medical Officer | Purchase | +8,800 | $4.61 | $41K | 326,394 |
| 2011-06-09 | KING RICHARD Chief Executive Officer | Purchase | +3,500 | $4.56 | $16K | 126,957 |
| 2011-03-02 | KING RICHARD President and CEO | Grant or award | +123,457 | 123,457 | ||
| 2011-03-02 | KING RICHARD President and CEO | Grant or award · Stock Option (Right to Buy) | +115,208 | 115,208 | ||
| 2011-03-02 | Palmer Pamela P Chief Medical Officer | Grant or award | +67,594 | 317,594 |
Page 29 of 37 · 732 trades